Chronic cough in Korean adults: a literature review on common comorbidity

Sung-Yoon Kang; Gun-Woo Kim; Woo-Jung Song; Yoon-Seok Chang; Sang-Heon Cho

doi:10.5415/apallergy.2016.6.4.198

Journal List > Asia Pac Allergy > v.6(4) > 1060919

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Kang, Kim, Song, Chang, and Cho: Chronic cough in Korean adults: a literature review on common comorbidity

Current Review

Asia Pacific Allergy 2016; 6(4): 198-206.

Published online: 31 October 2016

DOI: https://doi.org/10.5415/apallergy.2016.6.4.198

Chronic cough in Korean adults: a literature review on common comorbidity

Sung-Yoon Kang^1,², Gun-Woo Kim³, Woo-Jung Song^1,², Yoon-Seok Chang^1,^2,⁴, Sang-Heon Cho^1,²

¹Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.

²Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 03080, Korea.

³Department of Internal Medicine, Kwangju Christian Hospital, Gwangju 61661, Korea.

⁴Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Korea.

Correspondence: Woo-Jung Song, MD. Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-ro, Chongno-gu, Seoul 03080, Korea. Tel: +82-2-2072-3241, Fax: +82-2-742-3291, swj0126@gmail.com

Received 17 October 2016 Accepted 20 October 2016

(open-access, http://creativecommons.org/licenses/by-nc/4.0/):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Chronic cough is a significant medical condition with high prevalence and a strong negative impact on the quality of life. Cough hypersensitivity is thought to underlie chronic cough, with several environmental and host factors interacting to cause neuronal sensitization and chronicity. Comorbid conditions affecting cough reflex pathways, such as upper airway diseases, asthma, and gastroesophageal reflux, play important roles in chronic cough. However, their prevalence may vary in patients living in different geographical regions or with different ethnicities. We conducted a literature review to examine common comorbidities in Korean adult patients with chronic cough, their clinical implications, and the issues that still need to be addressed in the development of clinical evidence of chronic cough in Korean adult patients.

Keywords: Asthma, Chronic cough, Epidemiology, Korea, Rhinitis

INTRODUCTION

Cough is a normal defensive mechanism to protect the lower airways [1], but it is also a common troublesome symptom leading to medical consultation [2]. Although criteria to differentiate between 'normal' and 'abnormal' cough are still not clearly defined, clinical observations suggest that cough in patients seeking medical attention is predominantly 'hypersensitive' in nature [3 4 5 6]. These patients typically complain that their cough is triggered by trivial or low levels of stimuli, such as perfume, cold air, or talking. 'Cough hypersensitivity syndrome,' as it is now termed, can be demonstrated in tussigen inhalation challenge tests using capsaicin or citric acid [7 8] and is thought to underlie the phenomenon of abnormal troublesome cough [9 10 11].

A common example of cough hypersensitivity is upper respiratory tract infection (URTI) by rhinovirus [12]. Human neuronal cells infected by rhinovirus can exhibit up-regulated expression of transient receptor potential (TRP) ion channels [13]. Whether cough hypersensitivity in viral infection benefits the virus (facilitating its transmission) or the host (rapid viral clearance) is unknown, but it is mostly self-limiting, disappearing within 2 weeks. In some individuals with URTI, cough hypersensitivity may persist somewhat longer; this postinfectious cough consists of a large proportion of subacute cough (3–8 weeks in duration) patients [14]. However, hypersensitive cough frequently does not remit and may persist for months or years, which is termed as 'chronic cough' (≥8 weeks in duration). Chronic cough is a significant medical condition with a high prevalence and a strong negative impact on the quality of life [15 16].

Several factors are postulated to underlie the chronicity of cough hypersensitivity. Important among these are comorbidities that affect cough reflex pathways [15]. In the lower airways, type 2 or allergic inflammation, which is frequently found in asthma, can induce a phenotypic switch in sensory neurons and induce cough hypersensitivity [16]. Eosinophilic airway inflammation is associated with chronic cough, even in the absence of asthma [17]. Upper airway inflammation may not directly sensitize vagal pathways but it can modulate cough sensitivity [18 19]. Additionally, gastroesophageal reflux can cause or trigger cough hypersensitivity, via neuronal sensitization [20]. These are major conditions of high prevalence and clinical relevance in patients with chronic cough, and their identification and management contribute to cough resolution. Accordingly, these comorbidities are regarded as priority targets in the diagnostic pathways specified in international guidelines for chronic cough [21 22].

However, the prevalence of major comorbid conditions may vary by region. For example, gastroesophageal reflux disease (GERD) is seen in 10%–30% of chronic cough patients in Western populations but in <10% of those in East Asian populations [23]. Cough variant asthma (or asthma-related cough) is commonly prevalent in both groups. Upper airway cough syndrome, also called postnasal drip syndrome or rhinitis/rhinosinusitis-related cough, also has a variable but relatively high prevalence [23]. In our recent review of Asian studies, infectious diseases such as pulmonary tuberculosis and paragonimiasis were identified as important causes of chronic cough in several South and Southeast Asian countries [24]. While the geographic differences reported in the literature may partly result from methodological heterogeneities among studies, they also suggest the necessity to tailor diagnostic pathways to the relevant geographical or ethnic population.

In Korea, chronic cough is reported to have a prevalence of 3%–5% in community-based adult populations [25 26]. A questionnaire survey found that physicians recognized upper airway diseases and asthma as major conditions associated with chronic cough in Korean patients [27]. Previous individual studies also cited these two common conditions among Korean adult patients [28 29 30], in contrast to the low prevalence of GERD-related cough (1.7%) (9 of 531). The latter was determined in a study that included 24-hour ambulatory esophageal pH monitoring [30]. Given the population- and time-dependent variations in the prevalence of comorbid conditions, we conducted a literature review to identify the as-yet unaddressed issues that should be taken into account in the clinical assessment of Korean adult patients with chronic cough.

LITERATURE SEARCH

The PubMed and KoreaMed databases were searched to identify studies on the clinical epidemiology of chronic cough in Korean adult patients. Publications were selected if they reported the prevalence of major comorbid conditions (asthma, upper airway diseases, or GERD) or infectious diseases within the chronic cough population, either as a primary or secondary outcome. A manual search was conducted using Google. The search was updated until September 2016, and the publication language was not restricted.

COMMON COMORBIDITIES IN ADULT PATIENTS WITH CHRONIC COUGH IN KOREA

The 18 studies published between 1995 and 2014 (Table 1) [5 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44] were conducted at referral clinics at the level of single university hospitals. As these studies varied with respect to study period and purposes, they differed widely in both their definition of chronic cough and their inclusion criteria. Three different cutoff criterion were used to define chronic cough: ≥3 weeks (n = 11), ≥8 weeks (n = 5), and ≥4 weeks (n = 2). Common inclusion criteria were normal chest X-rays, no history or underlying lung diseases, and no evidence of drug-induced cough.

Nonetheless, because there were considerable differences in the diagnostic criteria, particularly for upper airway disease (Table 2), we arbitrarily categorized postnasal drip syndrome, upper airway cough syndrome, and rhinitis- or rhinosinusitis-associated cough as 'upper airway diseases.' Cases in which there were no identifiable comorbid conditions (originally termed as 'idiopathic cough' or 'nondiagnostic case') were categorized as 'unexplained cough'. Overall, upper airway diseases and asthma (including eosinophilic bronchitis [EB]) were the most two common conditions, occurring in 40%–90% of the study populations (Table 1, Fig. 1).

Upper airway diseases

In Korean studies, upper airway diseases had a prevalence of 23.3%–67.5% and were thus more common than other conditions. However, because the definition of these diseases is largely based on subjective findings or empirical treatment responses, the exact proportion of upper-airway-disease-associated cough is difficult to establish. Moreover, this category includes several upper airway disease conditions [45], and each of which may have a distinct pattern of cough association. Direct causal relationships between upper airway diseases and cough have been questioned [46 47]; however, experimental studies suggest that upper airway conditions can up- or down-regulate cough hypersensitivity [18] and general population studies support a positive associations across age groups in various countries including Korea [26 48 49 50].

Asthma and EB

Asthma occurs in 6.3%–56.5% of chronic cough patients in Korea, and three studies that focused on 'asthma only' reported prevalence rates as high as 42%–48.5% [31 34 43]. A comparison of two series of analysis performed at the same cough clinic at a single tertiary institution (2007–2011 and 2012–203) revealed a decrease in the prevalence of asthma from 18.5% (2007–2011) to 6.3% (2012–2013) [5 44]. Whether this decreasing trend at the tertiary clinic was due to an increase in asthma screening activity at primary or secondary clinics is unclear.

EB is a clinical condition characterized by eosinophilic inflammation in nonasthmatic lower airways [17]. Its identification is highly relevant, as these patients respond very rapidly to corticosteroid therapy (within 1 or 2 weeks of treatment initiation) [17 51]. In eight Korean studies of EB, the prevalence of the disease ranged from 5.4%–40.8%, which is similar to rates in other countries, either Asian or Western. The prevalence of nonasthmatic EB in Western population, such as United Kingdom, Australia, or Turkey, was 7%–33% [52 53 54 55 56 57]. A recent multicenter study in China (n = 704) reported that the prevalence of nonasthmatic EB among chronic cough patients was 17.2% [58]. EB frequently overlaps with upper airway diseases, as demonstrated in a single-center study in Korea, where the comorbid rate of upper airway diseases among non-asthmatic EB patients was 59.3% [59].

The summed prevalence of asthma and EB was 25.7%–47%. As both diagnoses are based on the findings of objective tests, their high prevalence rates support early objective investigation or empirical treatment for both conditions in Korean patients. However, conventional diagnostic tests such as methacholine challenge and induced sputum tests are not feasible in most clinical settings. Instead, simple diagnostic tests, such as fractional exhaled nitric oxide (FeNO) measurement [60] or blood eosinophil determination, could aid in identifying asthmatic or eosinophilic cough patients who are likely to respond to corticosteroid therapy [61 62 63].

Gastroesophageal reflux disease

Several studies reported the prevalence of GERD in Korean cough patients, but this was mostly determined using subjective criteria. One study carried out 24-hour esophageal pH monitoring and found that only 1.7% of patients had acid-reflux-associated cough [30]. East Asian studies have reported a low prevalence of GERD-related cough (2% in a Japanese study and 10% in a Chinese study) [58 64], but in Western population studies the prevalence is as high as 36% [23]. This regional or ethnic difference has been attributed to different degrees of obesity or to different diets. In a Korean elderly community population survey, the prevalence rates of clinically diagnosed GERD and obesity (defined as body mass index ≥ 30 kg/m²) were only 1.1% and 3.8%, respectively, and neither condition was significantly related to chronic cough [26 65]. However, in the UK adult population, the prevalence rates of regurgitation and obesity were 15% and 20%, respectively; moreover, reflux was significantly associated with chronic cough [66]. As the prevalence of reflux disease has been increasing in the Korean population [67], the epidemiology of reflux-related cough will probably change in the coming years.

Infection-related cough

Several studies have examined the prevalence of pertussis among adult patients with cough, but not specifically for chronic cough. In earlier clinical study conducted at an outpatient clinic of a large university hospital in 2002–2003, only 2.9% of 102 adult patients with persistent cough (1- to 12-week duration) had positive polymerase chain reaction (PCR) for Bordetella pertussis [68]. In a multicenter study of 607 adult patients with bothersome cough (≥2 weeks) who were recruited from nonoutbreak, ordinary outpatient settings in 2009–2011, the positivity rate for pertussis on PCR was 0.7% [69]. In another study of 310 adolescent and adult patients with cough of 1- to 8-week duration (in Seoul and Incheon, 2009–2011), the pertussis positivity rate in culture, PCR, and serology tests was 1.0%, 3.2%, and 24.5%, respectively [70]. A case-control study found a positive association between acute Chlamydia pneumoniae infection and chronic cough [71]. However, in another study, only 1 of 68 patients with cough ≥3 weeks had a positive PCR for Chlamydia [42]. Prevalence of pulmonary tuberculosis or paragonimiasis infection among Korean adult patients with chronic cough is not reported. Among Korean patients (n = 36) with pulmonary paragonimiasis, 47% had cough [72]. As these studies did not specifically focus on chronic cough, their findings warrant further investigation of infection-related cough in the chronic cough population.

Smoking, medication, and lung parenchymal diseases

Cigarette smoke is an irritant and can activate TRPA1 channels [73]; it is thus considered a risk factor for cough. In experimental studies, guinea pigs exposed to cigarette smoke had heightened cough responses to capsaicin inhalation [74]. In general population studies, the prevalence of chronic cough was correlated significantly with the current smoking rate at the population level [75]. Conversely, in a 1-year Danish population-based intervention study, the cessation of smoking significantly reduced the rate of self-reported chronic cough [76]. According to the Korean National Health and Nutrition Examination Survey (KNHANES) 2010–2012, the current smoking rate in Korea is ~25% in the general population but twofold higher among individuals with current cough, indicating a significant relationship between cigarette smoking and current cough [77].

Angiotensin converting enzyme (ACE) inhibitor can up-regulate cough sensitivity [7]. The prevalence of ACE-induced cough was reported as 1.9% in an earlier study of Korean patients (1995–1996) [28]. However, as later studies commonly excluded those receiving ACE inhibitors as the selection criteria [5 30 37 38 39 42], its recent prevalence is unclear.

Chest X-rays are recommended at the initial stage of the diagnostic work-up for cough [21 22], but the prevalence of lung parenchymal diseases among patients seeking medical consultation for chronic cough was difficult to obtain in the present review. However, the KNHANES 2010–2012 analysis reported that the rate of any chest X-ray abnormality was 9.2% among adults without current cough vs. 18.7% among those with current chronic cough [77].

Unexplained cough

The reported prevalence of unexplained cough varies widely, from 5%–53%. However, given the considerable heterogeneity in diagnostic procedures and in the definitions of unexplained cough (idiopathic cough or nondiagnostic case) between studies, its prevalence cannot be reliably estimated. Rather, these findings point out the need for a consensus definition of unexplained cough and for prospective investigations to accurately determine the proportion of affected patients in Korea.

CLINICAL IMPLICATIONS AND ISSUES STILL TO BE ADDRESSED

In this brief review, we examine the proportion of common comorbid conditions in Korean adult patients with chronic cough and identified the clinical implications as well as the issues to be addressed in further studies. These can be stated as follows:

Upper airway diseases, asthma, and EB are by far the most frequent conditions accounting for 40%–90% of the study populations in Korea. These 3 conditions should thus be considered priority targets in developing clinical evidence and diagnostic pathways for Korean adult patients with chronic cough.
A diagnostic approach for asthma and EB would be helpful in the early stage of investigation, as the two conditions were reported by 25.7%–47% of the patients and can be objectively diagnosed. However, conventional diagnostic methods, such as methacholine challenge and induced sputum tests, are not available in most clinical settings. Alternative diagnostic algorithms utilizing convenient tests, such as FeNO or blood eosinophil counts, need to be developed.
GERD- and infection-related cough had low prevalence rates (<5% overall) but their epidemiology may change with time or outbreak and continuous updates are necessary. Meanwhile, the burden of infection-related cough needs to be examined specifically in the chronic cough population.
All previous Korean studies were conducted at referral clinics. Further studies at primary care level would help to develop clinical pathways for primary physicians.
Development of a consensus definition for 'unexplained cough' will improve our understanding of the intrinsic mechanisms of cough hypersensitivity.
Standardization of diagnostic protocols and definition will facilitate the development of clinical evidence in Korean patients with chronic cough.

Figures and Tables

Fig. 1

Common comorbid conditions in Korean adult patients with chronic cough.

Table 1

Prevalence of major comorbid conditions among adult chronic cough patients in Korea

A, normal radiological findings; B, normal pulmonary lung function; C, nonsmoker; D, noninfectious condition; E, no underlying lung disease; F, no history of drug-induced cough; G, no abnormal lung auscultation (wheezing or rale); PNDS, postnasal drip syndrome; UACS, upper airway cough syndrome; CVA, cough variant asthma; EB, eosinophilic bronchitis; GERD, gastroesophageal reflux disease; ACEI, angiotensin converting enzyme inhibitor; NA, not available.

^*Referral clinic at a university hospital. ^†Incidence rates were calculated based on the result of article. ^‡Incidence rates were calculated based on the result of raw data.

Table 2

Diagnostic criteria for major comorbid conditions with chronic cough among previous Korean adult studies

A, constellation of symptoms; B, positive physical examination; C, radiographic findings; D, clinical response to treatment; E, positive objective test; F, positive test of reflux; G, previous diagnosis by physician; GERD, gastroesophageal reflux disease.

ACKNOWLEDGEMENTS

This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C2175).

References

1. Brooks SM. Perspective on the human cough reflex. Cough. 2011; 7:10.

2. Morice AH. Epidemiology of cough. Pulm Pharmacol Ther. 2002; 15:253–259.

3. Vertigan AE, Gibson PG. Chronic refractory cough as a sensory neuropathy: evidence from a reinterpretation of cough triggers. J Voice. 2011; 25:596–601.

4. Matsumoto H, Tabuena RP, Niimi A, Inoue H, Ito I, Yamaguchi M, Otsuka K, Takeda T, Oguma T, Nakaji H, Tajiri T, Iwata T, Nagasaki T, Jinnai M, Matsuoka H, Mishima M. Cough triggers and their pathophysiology in patients with prolonged or chronic cough. Allergol Int. 2012; 61:123–132.

5. Song WJ, Kim JY, Jo EJ, Lee SE, Kim MH, Yang MS, Kang HR, Park HW, Chang YS, Min KU, Cho SH. Capsaicin cough sensitivity is related to the older female predominant feature in chronic cough patients. Allergy Asthma Immunol Res. 2014; 6:401–408.

6. Hilton E, Marsden P, Thurston A, Kennedy S, Decalmer S, Smith JA. Clinical features of the urge-to-cough in patients with chronic cough. Respir Med. 2015; 109:701–707.

7. Morice AH, Lowry R, Brown MJ, Higenbottam T. Angiotensin-converting enzyme and the cough reflex. Lancet. 1987; 2:1116–1118.

8. Millqvist E, Bende M, Löwhagen O. Sensory hyperreactivity: a possible mechanism underlying cough and asthma-like symptoms. Allergy. 1998; 53:1208–1212.

9. Morice AH, Millqvist E, Belvisi MG, Bieksiene K, Birring SS, Chung KF, Dal Negro RW, Dicpinigaitis P, Kantar A, McGarvey LP, Pacheco A, Sakalauskas R, Smith JA. Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J. 2014; 44:1132–1148.

10. Chung KF, McGarvey L, Mazzone SB. Chronic cough as a neuropathic disorder. Lancet Respir Med. 2013; 1:414–422.

11. Morice AH, Jakes AD, Faruqi S, Birring SS, McGarvey L, Canning B, Smith JA, Parker SM, Chung KF, Lai K, Pavord ID, van den Berg J, Song WJ, Millqvist E, Farrell MJ, Mazzone SB, Dicpinigaitis P. Chronic Cough Registry. A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response. Eur Respir J. 2014; 44:1149–1155.

12. Atkinson SK, Sadofsky LR, Morice AH. How does rhinovirus cause the common cold cough? BMJ Open Respir Res. 2016; 3:e000118.

13. Abdullah H, Heaney LG, Cosby SL, McGarvey LP. Rhinovirus upregulates transient receptor potential channels in a human neuronal cell line: implications for respiratory virus-induced cough reflex sensitivity. Thorax. 2014; 69:46–54.

14. Kwon NH, Oh MJ, Min TH, Lee BJ, Choi DC. Causes and clinical features of subacute cough. Chest. 2006; 129:1142–1147.

15. Song WJ, Chang YS, Morice AH. Changing the paradigm for cough: does 'cough hypersensitivity' aid our understanding? Asia Pac Allergy. 2014; 4:3–13.

16. Undem BJ, Taylor-Clark T. Mechanisms underlying the neuronal-based symptoms of allergy. J Allergy Clin Immunol. 2014; 133:1521–1534.

17. Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE. Chronic cough: eosinophilic bronchitis without asthma. Lancet. 1989; 1:1346–1348.

18. Plevkova J, Song WJ. Chronic cough in subjects with upper airway diseases: analysis of mechanisms and clinical applications. Asia Pac Allergy. 2013; 3:127–135.

19. Song WJ, Chang YS. Cough hypersensitivity as a neuro-immune interaction. Clin Transl Allergy. 2015; 5:24.

20. Houghton LA, Lee AS, Badri H, DeVault KR, Smith JA. Respiratory disease and the oesophagus: reflux, reflexes and microaspiration. Nat Rev Gastroenterol Hepatol. 2016; 13:445–460.

21. Morice AH, Fontana GA, Sovijarvi AR, Pistolesi M, Chung KF, Widdicombe J, O'Connell F, Geppetti P, Gronke L, De Jongste J, Belvisi M, Dicpinigaitis P, Fischer A, McGarvey L, Fokkens WJ, Kastelik J. ERS Task Force. The diagnosis and management of chronic cough. Eur Respir J. 2004; 24:481–492.

22. Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown KK, Canning BJ, Chang AB, Dicpinigaitis PV, Eccles R, Glomb WB, Goldstein LB, Graham LM, Hargreave FE, Kvale PA, Lewis SZ, McCool FD, McCrory DC, Prakash UB, Pratter MR, Rosen MJ, Schulman E, Shannon JJ, Smith Hammond C, Tarlo SM. American College of Chest Physicians (ACCP). Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129:1 Suppl. 1S–23S.

23. Niimi A. Geography and cough aetiology. Pulm Pharmacol Ther. 2007; 20:383–387.

24. Song WJ, Faruqi S, Klaewsongkram J, Lee SE, Chang YS. Chronic cough: an Asian perspective. Part 1: Epidemiology. Asia Pac Allergy. 2015; 5:136–144.

25. Shin C, Lee S, Abbott RD, Kim JH, Lee SY, In KH, Kimm K. Respiratory symptoms and undiagnosed airflow obstruction in middle-aged adults: the Korean Health and Genome Study. Chest. 2004; 126:1234–1240.

26. Song WJ, Morice AH, Kim MH, Lee SE, Jo EJ, Lee SM, Han JW, Kim TH, Kim SH, Jang HC, Kim KW, Cho SH, Min KU, Chang YS. Cough in the elderly population: relationships with multiple comorbidity. PLoS One. 2013; 8:e78081.

27. Kim SH, Kim SH, Song WJ, Kwon JW, Kim MH, Kim KM, Jeong JW, Kim SH, Ahn Y, Jo EJ, Lee SE, Lee JY, Lee JY, Kim CW, Kwon HS, Kim TB, Moon JY, Shin JW, Lee BJ. Work Group for Chronic Cough, the Korean Academy of Asthma, Allergy and Clinical Immunology. Allergists' Perceptions and Practices on the Management of Chronic Cough in Korea: A Questionnaire Survey. Korean J Asthma Allergy Clin Immunol. 2012; 32:239–253.

28. Jee YK, Oh HT, Lee KY, Kim KY, Cho SH, Min KU, Kim YY. A prospective study for spectrum and frequency of chronic cough in patients visiting out-patient clinic. J Asthma Allergy Clin Immunol. 1998; 18:222–231.

29. Joo JH, Park J, Park SJ, Seo MJ, Kim DJ, Uh ST, Kim YH, Park CS. Clinical features of eosinophilic bronchitis. Korean J Med. 2001; 60:77–84.

30. Kwon NH, Lee BJ, Choi DC. Chronic cough of unknown causes and gastroesophageal reflux disease: the incidence and treatment response. Korean J Med. 2005; 69:528–535.

31. Yoo B, Choi SW, Moon HB. Airway responsiveness in patients with chronic cough. Allergy. 1995; 15:223–229.

32. Cho YJ. Metacholine induced bronchial hyperreativity and atopic state in patients with chronic cough. Ewha Med J. 1997; 20:131–136.

33. Kim KH, Lee GT, Park SW, Oh JH, Ki SY, Moon SH, Jeong SH, Kim HT, Uh ST, Kim YH, Park CS, Jin BW. Airway hyperresponsiveness and etiology in patients with chronic cough. Tuberc Respir Dis. 1997; 44:146–153.

34. Oh YB, Mon CH, Kim HY, Lee SM. The diagnostic value of sputum eosinophil counts in patients with chronic cough. Korean J Allergy. 1997; 17:180–185.

35. Cho JH, Ryu JS, Lee HL. Chronic cough: the spectrum and the frequency of etiologies. Tuberc Respir Dis. 1999; 46:555–563.

36. Cho YS, Lee CK, Yoo B, Moon HB. Cough sensitivity and extrathoracic airway responsiveness to inhaled capsaicin in chronic cough patients. J Korean Med Sci. 2002; 17:616–620.

37. Jeon G, Jang SH, Song HG, Ha JW, Eom KS, Bahn JW, Kim DG, Shin TR, Park SM, Park YB, Kim CH, Hyun IG, Jung KS. Diagnostic performance of routine objective tests and cost-effective approach for chronic cough. Tuberc Respir Dis. 2004; 57:535–542.

38. Lee BJ, Min TH, Choi DC. Ever wheeze as a predictor of cough variant asthma. J Asthma Allergy Clin Immunol. 2004; 24:94–102.

39. Lee KH, Jang SH, Lee JH, Eom KS, Bahn JW, Kim DG, Shin TR, Park SM, Lee MG, Kim CH, Hyun IG, Jung KS. The role of inhaled corticosteroid in the management of chronic cough. Tuberc Respir Dis. 2006; 60:221–227.

40. Lee J, Kim M, Kim JH, Lee YR, Kim S, Kim Y. A cheaper, faster way to resolve chronic cough. J Fam Pract. 2007; 56:641–646.

41. Shin JY, Lee JE, Park JW, Jung SY, Yoo SJ, Yoon JH, Park HS, Kim SY, Kim JO. Validation of a modified ECRHS questionnaire for diagnosing asthma in patients with chronic cough. Korean J Med. 2009; 77:734–740.

42. Chun SY, Park KO, Park YB, Choi JH, Lee JY, Mo EK, Park SH, Kim CH, Lee CY, Hwang YI, Jang SH, Shin TR, Park SM, Kim DG, Lee MG, Hyun IG, Jung KS. Infection rate of chlamydia pneumoniae in patients with chronic cough. Tuberc Respir Dis. 2010; 69:426–433.

43. Kim YJ, Callaway Z, Kim HB, Kim CK. The efficacy of eosinophilic degranulation proteins for diagnosing asthma in chronic cough patients. Korean J Asthma Allergy Clin Immunol. 2010; 30:293–298.

44. Kim JY, Kang MG, Lee SE, Lee SY, Kim MH, Yang MS, Song WJ, Kang HR, Park HW, Cho SH, Min KU. Capsaicin cough hypersensitivity among adult patients with chronic cough. Seoul: Korean Academy of Asthma Allergy and Clinical Immunology Annual Congress;2012.

45. Pratter MR. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest. 2006; 129:1 Suppl. 63S–71S.

46. O'Hara J, Jones NS. "Post-nasal drip syndrome": most patients with purulent nasal secretions do not complain of chronic cough. Rhinology. 2006; 44:270–273.

47. Morice AH. Post-nasal drip syndrome--a symptom to be sniffed at? Pulm Pharmacol Ther. 2004; 17:343–345.

48. Janson C, Chinn S, Jarvis D, Burney P. Determinants of cough in young adults participating in the European Community Respiratory Health Survey. Eur Respir J. 2001; 18:647–654.

49. Guerra S, Sherrill DL, Baldacci S, Carrozzi L, Pistelli F, Di Pede F, Viegi G. Rhinitis is an independent risk factor for developing cough apart from colds among adults. Allergy. 2005; 60:343–349.

50. Bende M, Millqvist E. Prevalence of chronic cough in relation to upper and lower airway symptoms; the Skövde population-based study. Front Physiol. 2012; 3:251.

51. Gibson PG, Hargreave FE, Girgis-Gabardo A, Morris M, Denburg JA, Dolovich J. Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid. Clin Exp Allergy. 1995; 25:127–132.

52. Ayik SO, Başoğlu OK, Erdínç M, Bor S, Veral A, Bílgen C. Eosinophilic bronchitis as a cause of chronic cough. Respir Med. 2003; 97:695–701.

53. Birring SS, Parker D, Brightling CE, Bradding P, Wardlaw AJ, Pavord ID. Induced sputum inflammatory mediator concentrations in chronic cough. Am J Respir Crit Care Med. 2004; 169:15–19.

54. Brightling CE, Ward R, Goh KL, Wardlaw AJ, Pavord ID. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med. 1999; 160:406–410.

55. Carney IK, Gibson PG, Murree-Allen K, Saltos N, Olson LG, Hensley MJ. A systematic evaluation of mechanisms in chronic cough. Am J Respir Crit Care Med. 1997; 156:211–216.

56. McGarvey LP, Heaney LG, Lawson JT, Johnston BT, Scally CM, Ennis M, Shepherd DR, MacMahon J. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax. 1998; 53:738–743.

57. O'Connell F, Thomas VE, Pride NB, Fuller RW. Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med. 1994; 150:374–380.

58. Lai K, Chen R, Lin J, Huang K, Shen H, Kong L, Zhou X, Luo Z, Yang L, Wen F, Zhong N. A prospective, multicenter survey on causes of chronic cough in China. Chest. 2013; 143:613–620.

59. Sohn SW, Yang MS, Lee SH, Song WJ, Lee SM, Kwon HS, Kim DI, Park CH, Park HW, Chang YS, Kim SS, Cho SH, Min KU, Kim YY. Evaluation of the causes of chronic cough with sputum eosinophilia. Korean J Asthma Allergy Clin Immunol. 2007; 27:125–130.

60. Song WJ, Kwon JW, Kim EJ, Lee SM, Kim SH, Lee SY, Kim SH, Park HW, Chang YS, Kim WK, Shim JY, Seo JH, Kim BJ, Kim HB, Song DJ, Jang GC, Jang AS, Park JW, Yoon HJ, Lee JS, Cho SH, Hong SJ. Clinical application of exhaled nitric oxide measurements in a korean population. Allergy Asthma Immunol Res. 2015; 7:3–13.

61. Chatkin JM, Ansarin K, Silkoff PE, McClean P, Gutierrez C, Zamel N, Chapman KR. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am J Respir Crit Care Med. 1999; 159:1810–1813.

62. Oh MJ, Lee JY, Lee BJ, Choi DC. Exhaled nitric oxide measurement is useful for the exclusion of nonasthmatic eosinophilic bronchitis in patients with chronic cough. Chest. 2008; 134:990–995.

63. Song WJ, Won HK, Moon SD, Chung SJ, Kang SY, Sohn KH, Kim JY, Kim BK, Lim KH, Kim MY, Yang MS, Park HW, Chang YS, Lee BJ, Morice AH, Cho SH. Could fractional exhaled nitric oxide test be useful in predicting inhaled corticosteroid responsiveness in chronic cough? A systematic review. J Allergy Clin Immunol Pract. 2016; 10. 01. [Epub]. DOI: 10.1016/j.jaip.2016.07.017.

64. Fujimura M, Abo M, Ogawa H, Nishi K, Kibe Y, Hirose T, Nakatsumi Y, Iwasa K. Importance of atopic cough, cough variant asthma and sinobronchial syndrome as causes of chronic cough in the Hokuriku area of Japan. Respirology. 2005; 10:201–207.

65. Song WJ, Kim SH, Lim S, Park YJ, Kim MH, Lee SM, Lee SB, Kim KW, Jang HC, Cho SH, Min KU, Chang YS. Association between obesity and asthma in the elderly population: potential roles of abdominal subcutaneous adiposity and sarcopenia. Ann Allergy Asthma Immunol. 2012; 109:243–248.

66. Ford AC, Forman D, Moayyedi P, Morice AH. Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. Thorax. 2006; 61:975–979.

67. Kim KM, Cho YK, Bae SJ, Kim DS, Shim KN, Kim JH, Jung SW, Kim N. Prevalence of gastroesophageal reflux disease in Korea and associated health-care utilization: a national population-based study. J Gastroenterol Hepatol. 2012; 27:741–745.

68. Park WB, Park SW, Kim HB, Kim EC, Oh M, Choe KW. Pertussis in adults with persistent cough in South Korea. Eur J Clin Microbiol Infect Dis. 2005; 24:156–158.

69. Park S, Lee MG, Lee KH, Park YB, Yoo KH, Park JW, Kim C, Lee YC, Park JS, Kwon YS, Seo KH, Kim HJ, Kwak SM, Kim JO, Lim SY, Sung HY, Jung SO, Jung KS. A Multicenter study of pertussis infection in adults with coughing in Korea: PCR-based study. Tuberc Respir Dis (Seoul). 2012; 73:266–272.

70. Lee SY, Han SB, Kang JH, Kim JS. Pertussis prevalence in korean adolescents and adults with persistent cough. J Korean Med Sci. 2015; 30:988–990.

71. Kim WJ, Lee HY, Lee ME, Lee SJ. Serology of Chlamydia pneumoniae in patients with chronic cough. Respirology. 2006; 11:805–808.

72. Jeon K, Koh WJ, Kim H, Kwon OJ, Kim TS, Lee KS, Han J. Clinical features of recently diagnosed pulmonary paragonimiasis in Korea. Chest. 2005; 128:1423–1430.

73. Birrell MA, Belvisi MG, Grace M, Sadofsky L, Faruqi S, Hele DJ, Maher SA, Freund-Michel V, Morice AH. TRPA1 agonists evoke coughing in guinea pig and human volunteers. Am J Respir Crit Care Med. 2009; 180:1042–1047.

74. Belvisi MG, Birrell MA, Khalid S, Wortley MA, Dockry R, Coote J, Holt K, Dubuis E, Kelsall A, Maher SA, Bonvini S, Woodcock A, Smith JA. Neurophenotypes in airway diseases: insights from translational cough studies. Am J Respir Crit Care Med. 2016; 193:1364–1372.

75. Song WJ, Chang YS, Faruqi S, Kang MK, Kim JY, Kang MG, Kim S, Jo EJ, Lee SE, Kim MH, Plevkova J, Park HW, Cho SH, Morice AH. Defining chronic cough: a systematic review of the epidemiological literature. Allergy Asthma Immunol Res. 2016; 8:146–155.

76. Pisinger C, Godtfredsen NS, Jørgensen T. Smoking reduction and cessation reduce chronic cough in a general population: the Inter99 study. Clin Respir J. 2008; 2:41–46.

77. Kang MG, Song WJ, Chang YS, Kim SS, Kim MK, Chang SI, Min KU, Cho SH. Epidemiology of chronic cough in Korea: a nationwide database analysis (2010-2012). In : 34th European Academy of Allergy and Clinical Immunology (EAACI) Congress 2015; 2015 Jun 6-10; Barcelona, Spain. Meeting Abstract No. 1625.

TOOLS

Similar articles